4Craig WA.The future-can we learn from the past[ J] ? Diagn Micro -biol Infect Dis,1997 ;27:49 -53.
5Cars O.Efficacy of beta-lactam antibiotics:integration of pharmacokinetics and pharmacodynamics[ J].Diagn Microbiol Infect Dis,1997;27:29-33.
6Craig WA.Antimicrobial resistant issues of the future[J].Diagn Microbial Infect Dis,1996 ;25:213-217.
7Woodnutt G,Berry V.Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae[ J].Antimicrob Agents Chemother,1999 ;43:29-34.
8Drusano GL,Craig WA.Relevance of pharmacokinetics and pharmaco-dynamics in the selection of antibiotics for respiratory tract infections[J].J Chemother,1997; 9:38 -44.
9Schentag JJ.Antimicrobial action and pharmacokinetics/ pharmacody-namics:the use of AUIC to improve efficacy and avoid resistance[J].J Chemother,1999; 11:426-439.
10Craig WA.Choosing an antibiotic on the basis of pharmacodynamics[J].Ear Nose Throat J,1998 ;77:7-11.
